|
A dirty little secret in the world of women’s healthcare is the relatively few data guiding medical decision-making. Recent reports suggest less than 50% of all medical treatments have any data to support their efficacy. Of that evidence, much could be suspect given the rampant payments from pharmaceutical and device companies to physicians and other decision-makers, plus the well-documented publishing bias and even fraud plaguing the scientific publishing industry.
In women’s health, matters are even worse. Not only are evidenced-based, clinical practice guidelines nearly non-existent in O
|
